NCT07805252
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07805252
Title Trial to Study the Safety, Pharmacokinetics and Preliminary Antitumour Activity of ODM-216 in Patients With Cancer (BICIDES)
Acronym BICIDES
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Orion Corporation, Orion Pharma
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
START Rioja - Hospital Universitario San Pedro RECRUITING Logroño La Rioja 26006 Spain Details
NEXT Oncology - Hospital Quironsalud Madrid RECRUITING Madrid Pozuelo de Alarcón - Madrid 28223 Spain Details
START Barcelona - HM Nou Delfos RECRUITING Barcelona 08023 Spain Details
Clinica Universidad de Navarra - Madrid RECRUITING Madrid 28027 Spain Details
Hospital Universitario Fundacion Jimenez Diaz - START MADRID RECRUITING Madrid 28040 Spain Details
START Madrid - CIOCC FM Sanchinarro RECRUITING Madrid 28050 Spain Details
Clínica Universidad de Navarra. Pamplona RECRUITING Pamplona 31008 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field